Tang Capital Management LLC Atea Pharmaceuticals, Inc. Transaction History
Tang Capital Management LLC
- $1.67 Billion
- Q2 2025
A detailed history of Tang Capital Management LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 4,889,200 shares of AVIR stock, worth $17.2 Million. This represents 1.05% of its overall portfolio holdings.
Number of Shares
4,889,200
Previous 4,800,000
1.86%
Holding current value
$17.2 Million
Previous $14.4 Million
22.64%
% of portfolio
1.05%
Previous 0.93%
Shares
8 transactions
Others Institutions Holding AVIR
# of Institutions
110Shares Held
48.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY9.12MShares$32 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$26.7 Million20.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$17.2 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$8.72 Million2.68% of portfolio
-
Geode Capital Management, LLC Boston, MA1.93MShares$6.76 Million0.0% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $292M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...